首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

到 2030 年臨床試驗患者招募服務的市場預測：按治療領域、階段、年齡層和地區進行的全球分析

市場調查報告書

商品編碼

1383404

到 2030 年臨床試驗患者招募服務的市場預測：按治療領域、階段、年齡層和地區進行的全球分析

Clinical Trial Patient Recruitment Services Market Forecasts to 2030 - Global Analysis By Therapeutic Areas, Phase, Age Group and By Geography

出版日期: 2023年11月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，2023 年全球臨床試驗患者招募服務市場規模為 11.9 億美元，預計在預測期內年複合成長率為 11.5%，到 2030 年將達到 25.5 億美元。

專門幫助研究人員和製藥公司尋找和招募合格的臨床試驗患者進行臨床試驗的服務稱為臨床試驗患者招募服務。為了更快開始臨床試驗，病患招募服務可以加快識別和招募合格參與者的過程。為了讓研究人員更了解治療方法在不同人群中的有效性和安全性，擁有更多樣化和代表性的患者群體至關重要，而這可以透過患者招募服務來保證，這是一個要素。

根據 ClinicalTrial.gov 統計，過去年度臨床試驗增加了 49.2%。

臨床試驗數量增加

推動臨床試驗患者招募服務市場的主要因素之一是臨床試驗數量的增加。藥物研究、醫學研究以及對新療法和治療方法的探索的持續發展是臨床試驗活動增加的主要驅動力。隨著製藥和生物技術公司、學術機構和研究機構配合措施將新藥、醫療設備和治療方法推向市場，對專業患者招募服務的需求不斷增加。

預算限制

預算限制是研究機構和製藥公司的典型問題。病患招募服務對於臨床實驗的順利進行至關重要，但其成本是一個主要因素。這些服務通常涉及大量成本，包括僱用員工、使用最尖端科技、廣告和推廣計劃來尋找和聯繫潛在的臨床試驗參與者。此外，患者招募服務提供者可能會感到在競爭激烈的市場中提供競爭的價格的壓力，這可能會影響報酬率以及投資尖端策略和技術的能力。因此，這是市場成長的主要障礙。

先進的技術

許多招聘機構正在利用人工智慧和資料分析等先進技術來提高參與者識別的準確性和效率。患者招募服務擴大使用資料分析，透過篩選大型資料來快速且準確地識別潛在的臨床試驗參與者。這種分析方法可以透過系統地評估各種患者特徵和病歷來確定符合每個臨床試驗確切要求的人。這些因素正在推動市場需求。

法規挑戰

臨床試驗的法規環境複雜且不斷變化。招聘機構可能會發現很難遵守不斷變化的法規，例如資料保護和知情同意法規。此外，對於適用於臨床試驗的病患隱私、資料保護和知情同意也有嚴格的法規。患者招募服務可能難以遵守法規機構關於患者資料收集、儲存和共用的嚴格準則。這些因素都阻礙了市場的擴張。

COVID-19 的影響

COVID-19 大流行對臨床試驗患者招募服務市場產生了重大影響。許多正在進行的臨床試驗因疫情而中斷，這對臨床試驗入組和患者招募產生了重大負面影響。逐步淘汰、旅行禁令和使用醫療設施的限制使得臨床實驗難以按計劃進行。患者招募服務與高科技公司合作，提高遠端監控能力並收集即時患者資料，同時最大限度地減少親自就診的需要。

預計預測期內呼吸系統疾病領域規模最大

預計呼吸系統疾病領域將佔最大佔有率。臨床試驗招募服務呼吸疾病部門專注於臨床研究的特定領域，致力於開發各種呼吸系統疾病的治療方法。臨床試驗對於評估新藥、吸入器、生物製藥和醫療設備增強肺功能、減輕症狀和預防病情惡化的安全性和有效性至關重要。

預計第二期細分市場在預測期間內年複合成長率最高

預計二期業務在預測期內將出現良好成長。在臨床研究中，II期臨床試驗是I期試驗之後、III期試驗前發生的重要階段。 II 期臨床試驗的主要目的是評估新治療方法和藥物在較大患者群體中的安全性和有效性。 II 期臨床試驗病患招募服務負責識別和招募符合臨床實驗試驗方案中具體要求的合格參與者。

佔比最高的地區

由於北美正在進行大量活躍的臨床試驗，因此在估計期間佔據最大的市場佔有率，預計市場將快速擴張。該產業也受到大量研發支出和政府對臨床試驗的資助的推動。北美的行業成長是由頂級委外研發機構(CRO) 的存在推動的，這些組織提供患者招募等廣泛的支援服務，以及全球製藥和生物製藥公司的積極參與。

複合年複合成長率最高的地區：

預計亞太地區在預測期內將實現盈利成長。臨床試驗向印度、日本和韓國等新興國家的離岸外包正在增加。這是因為患者群龐大且臨床試驗成本低廉，進一步促進了區域擴張。合格的醫療人員、強大的醫院網路以及研發基礎設施的發展都有助於亞太市場的擴張。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

公司簡介
- 其他市場參與企業的綜合分析（最多 3 家公司）
- 主要企業SWOT分析（最多3家企業）
區域分割
- 根據客戶興趣對主要國家的市場估計/預測/年複合成長率（註：基於可行性檢查）
競爭基準化分析
- 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 中東和非洲其他地區

第9章進展

合約、夥伴關係、協作和合資企業
收購和合併
新產品發布
業務擴展
其他關鍵策略

第10章公司簡介

Clinical Site Services
Clara Health
Worldwide Clinical Trials
Clariness
Veristat
PPD Inc
BBK Worldwide
Elligo Health Research
Antidote Technologies, Inc.
IQVIA
Matthews Media Group Inc.
Conduent, Inc.
Biorasi, LLC
Trialfacts
Syneos Health

簡介目錄圖表

Product Code: SMRC24253

According to Stratistics MRC, the Global Clinical Trial Patient Recruitment Services Market is accounted for $1.19 billion in 2023 and is expected to reach $2.55 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Services specifically designed to assist researchers and pharmaceutical companies in finding and recruiting qualified subjects for their clinical trials are known as clinical trial patient recruitment services. In order to help clinical trials get underway more quickly, patient recruitment services can speed up the process of identifying and enrolling eligible participants. For researchers to better understand a treatment's efficacy and safety across a range of demographic groups it is imperative to have a more diverse and representative patient population, which is a factor that patient recruitment services can help ensure.

According to ClinicalTrial.gov, there has been a 49.2% rise in clinical trials over the past 5 years.

Market Dynamics:

Driver:

Rising Number of Clinical Trials

One major factor propelling the market for clinical trial patient recruitment services is the rise in the number of clinical trials. The ongoing developments in pharmaceutical research, medical research, and the search for novel therapies and treatments are the main drivers of this rise in clinical trial activity. Specialized patient recruitment services are in increasing demand as pharmaceutical and biotechnology companies, academic institutions, and research organizations step up their efforts to introduce novel drugs, medical devices, and therapies to the market.

Restraint:

Budgetary restrictions

Budgetary restrictions are a typical problem for research institutions and pharmaceutical companies. Although patient recruitment services are essential to the smooth running of trials, their costs can be a significant factor. These services usually come with a number of costs, such as hiring staff, using cutting-edge technologies, advertising, and outreach programs to find and connect possible trial participants. Furthermore, providers of patient recruitment services may feel pressured to offer competitive pricing in a market that is fiercely competitive, which could affect their profit margins and capacity to make investments in cutting-edge tactics and technologies. Therefore, it is a significant barrier to market growth.

Opportunity:

Advanced technologies

Numerous recruitment agencies use advanced technologies, like artificial intelligence and data analytics, to improve participant identification accuracy and efficiency. Data analytics is being used by patient recruitment services in increasing numbers to quickly and accurately identify possible trial participants by sorting through large datasets. This analytical method makes it possible to identify people who fit the precise requirements of each clinical trial by methodically evaluating a variety of patient characteristics and medical histories. These factors propel market demand.

Threat:

Regulatory challenges

The regulatory landscape for clinical trials is complex and subject to constant change. Recruitment agencies may find it difficult to remain compliant with changing regulations, such as those pertaining to data protection and informed consent. Additionally, there are stringent regulations pertaining to patient privacy, data protection, and informed consent that apply to clinical trials. Patient recruitment services may find it difficult to comply with regulatory bodies' strict guidelines when it comes to gathering, storing, and sharing patient data. These factors hamper market expansion.

COVID-19 Impact

The COVID-19 pandemic has had a significant impact on the clinical trial patient recruitment services market. Numerous ongoing clinical trials were disrupted by the pandemic, which had a significant negative impact on trial enrolment and patient recruitment. Phase-outs, travel bans, and restricted access to medical facilities made it difficult to carry out trials as scheduled. In order to improve remote monitoring capabilities and collect real-time patient data while minimizing the need for in-person visits, patient recruitment services worked with tech companies.

The respiratory diseases segment is expected to be the largest during the forecast period

The respiratory diseases segment is estimated to hold the largest share. The Clinical Trial Patient Recruitment Services' respiratory diseases section focuses on a particular field of clinical research that is committed to the creation of cures and treatments for a range of respiratory ailments. For the purpose of assessing the safety and effectiveness of novel medications, inhalers, biologics, and medical devices intended to enhance lung function, reduce symptoms, or stop exacerbations, clinical trials are crucial.

The phase II segment is expected to have the highest CAGR during the forecast period

The phase II segment is anticipated to have lucrative growth during the forecast period. In the clinical research spectrum, Phase II clinical trials are a crucial stage that comes after Phase I trials and before Phase III trials. The main goals of Phase II trials are to evaluate a new treatment or medication's safety and effectiveness in a larger patient population. The Phase II segment recruitment services are responsible for identifying and enrolling eligible participants who meet the precise requirements specified in the trial protocol.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the large number of active clinical trials in the region, the market is anticipated to increase rapidly. Significant R&D expenditures and government funding for clinical studies also drive the industry. The industry's growth in North America has been facilitated by the existence of top contract research organizations (CROs) that provide extensive support services, such as patient recruiting, and by the active involvement of global pharmaceutical and biopharmaceutical corporations.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. There is an increase in off shoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is because there is a large patient pool and trials are inexpensive, which further promotes regional expansion. The availability of qualified medical professionals, a robust hospital network, and developed clinical research infrastructure are all contributing to the Asia-Pacific market's expansion.

Key players in the market

Some of the key players in the Clinical Trial Patient Recruitment Services Market include: Clinical Site Services, Clara Health, Worldwide Clinical Trials, Clariness, Veristat, PPD Inc, BBK Worldwide, Elligo Health Research, Antidote Technologies, Inc., IQVIA, Matthews Media Group Inc., Conduent, Inc., Biorasi, LLC, Trialfacts and Syneos Health.

Key Developments:

In August 2023, Worldwide Clinical partners with Cybin for psychedelic-based treatments. Cybin, a biopharma developing psychedelic-based treatment options for mental health issues.

In December 2021, worldwide clinical Trials and WCG partner to accelerate and streamline global safety event distribution. Worldwide offers a comprehensive suite of pharmacovigilance capabilities, including a regulatory intelligence database that is unique to the company and enhanced by WCG's proprietary Safety Vigilance portal.

Therapeutic Areas Covered:

Central Nervous System
Anti-Infective
Endocrine
Respiratory Diseases
Cardiovascular
Pain & Anaesthesia
Oncology
Dermatological Disorders
Haematological Disorders
Other Therapeutic Areas

Phases Covered:

Phase I
Phase II
Phase Ill
Phase IV

Age Groups Covered:

Child
Adult

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas

5.1 Introduction
5.2 Central Nervous System
5.3 Anti-Infective
5.4 Endocrine
5.5 Respiratory Diseases
5.6 Cardiovascular
5.7 Pain & Anesthesia
5.8 Oncology
5.9 Dermatological Disorders
5.10 Hematological Disorders
5.11 Other Therapeutic Areas

6 Global Clinical Trial Patient Recruitment Services Market, By Phase

6.1 Introduction
6.2 Phase I
6.3 Phase II
6.4 Phase Ill
6.5 Phase IV

7 Global Clinical Trial Patient Recruitment Services Market, By Age Group

7.1 Introduction
7.2 Child
7.3 Adult

8 Global Clinical Trial Patient Recruitment Services Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Clinical Site Services
10.2 Clara Health
10.3 Worldwide Clinical Trials
10.4 Clariness
10.5 Veristat
10.6 PPD Inc
10.7 BBK Worldwide
10.8 Elligo Health Research
10.9 Antidote Technologies, Inc.
10.10 IQVIA
10.11 Matthews Media Group Inc.
10.12 Conduent, Inc.
10.13 Biorasi, LLC
10.14 Trialfacts
10.15 Syneos Health

簡介目錄圖表

List of Tables

Table 1 Global Clinical Trial Patient Recruitment Services Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 3 Global Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 4 Global Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 5 Global Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 6 Global Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 7 Global Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 8 Global Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 9 Global Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 10 Global Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 11 Global Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 12 Global Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 13 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 14 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 15 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 16 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 17 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 18 Global Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 19 Global Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 20 Global Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 21 North America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 22 North America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 23 North America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 24 North America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 25 North America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 26 North America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 27 North America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 28 North America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 29 North America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 30 North America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 31 North America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 32 North America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 33 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 34 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 35 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 36 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 37 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 38 North America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 39 North America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 40 North America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 41 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 42 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 43 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 44 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 45 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 46 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 47 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 48 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 49 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 50 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 51 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 52 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 53 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 54 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 55 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 56 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 57 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 58 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 59 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 60 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 61 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 62 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 63 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 64 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 65 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 66 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 67 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 68 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 69 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 70 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 71 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 72 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 73 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 74 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 75 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 76 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 77 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 78 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 79 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 80 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 81 South America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 82 South America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 83 South America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 84 South America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 85 South America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 86 South America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 87 South America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 88 South America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 89 South America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 90 South America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 91 South America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 92 South America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 93 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 94 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 95 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 96 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 97 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 98 South America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 99 South America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 100 South America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 101 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 102 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 103 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 104 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 105 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 106 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 107 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 108 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 109 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 110 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 111 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 112 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 113 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 114 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 115 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 116 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 117 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 118 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 119 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 120 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)